BTC Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.1M Buy
13,431
+834
+7% +$852K 0.98% 28
2026
Q1
$11.6M Buy
12,597
+1,225
+11% +$1.24M 0.78% 33
2025
Q4
$12.2M Sell
11,372
-208
-2% -$199K 0.85% 32
2025
Q3
$8.84M Buy
11,580
+582
+5% +$433K 0.61% 44
2025
Q2
$8.56M Buy
10,998
+496
+5% +$385K 0.7% 40
2025
Q1
$8.67M Buy
10,502
+1,265
+14% +$1.05M 0.79% 38
2024
Q4
$7.13M Sell
9,237
-1,390
-13% -$1.15M 0.66% 49
2024
Q3
$9.41M Buy
10,627
+3,073
+41% +$2.76M 0.84% 37
2024
Q2
$6.84M Buy
7,554
+5,713
+310% +$4.57M 0.63% 54
2024
Q1
$1.43M Buy
+1,841
New +$1.31M 0.13% 118
2023
Q3
$989K Hold
1,841
0.11% 132
2023
Q2
$863K Hold
1,841
0.09% 136
2023
Q1
$632K Sell
1,841
-80
-4% -$27K 0.07% 136
2022
Q4
$703K Buy
1,921
+201
+12% +$71.3K 0.08% 141
2022
Q3
$556K Buy
1,720
+125
+8% +$39.6K 0.07% 144
2022
Q2
$517K Sell
1,595
-10
-0.6% -$3K 0.06% 156
2022
Q1
$460K Sell
1,605
-150
-9% -$38.6K 0.05% 192
2021
Q4
$485K Buy
+1,755
New +$445K 0.05% 182
2015
Q3
Sell
-2,455
Closed -$204K 181
2015
Q2
$204K Buy
+2,455
New +$187K 0.05% 146

Other funds holding LLY

BTC Capital Management's LLY Position: Q2 2026 in Review

BTC Capital Management increased its Eli Lilly (LLY) stake by 6.6% in Q2 2026, buying an estimated $852K and bringing the position to 13,431 shares worth $16.1M. The position accounts for 0.98% of the portfolio, ranked #28.

BTC Capital Management first reported a position in LLY in Q2 2015 and has held it in 19 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BTC Capital Management held 13,431 shares of Eli Lilly worth $16.1M as of Q2 2026.
  • BTC Capital Management bought 834 Eli Lilly shares in Q2 2026, an estimated $852K.
  • Eli Lilly made up 0.98% of BTC Capital Management's portfolio in Q2 2026, its #28 holding.
  • BTC Capital Management first reported a position in Eli Lilly in Q2 2015 and has held it in 19 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BTC Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.